Health & Public Health

Rising U.S. IVF Costs Drive Patients to Seek Treatment Abroad

Soaring costs for in vitro fertilization (IVF) and limited insurance coverage have led an increasing number of Americans to seek fertility treatments overseas, according to data from fertility experts and recent studies. Clinics in countries like Greece and Spain offer significantly lower prices, combining affordability with additional travel benefits.

What Happened

In 2024, Emilie and Justin Solomon traveled to Greece for IVF treatment after being quoted $40,000 for a single IVF cycle in their home state of Florida. Their trip, kept discreet from family and friends, included multiple visits to clinics in Athens, where comprehensive treatment cost roughly $12,000 excluding travel expenses. The couple’s journey exemplifies a growing trend: Americans crossing borders to obtain fertility care at a fraction of domestic prices.

This shift comes amid escalating treatment costs in the United States, where a study by Axene Health Partners and the Women’s Reproductive Health Foundation put the average IVF cycle cost above $29,000 in 2024—the equivalent of 35% of median annual household income. Additional services such as genetic testing, embryo storage, and prenatal care can drive total expenses beyond $54,000 per IVF-conceived birth.

Demand for IVF and other assisted reproductive technologies has resulted in more than 100,000 babies born via IVF in the U.S. during 2024—a record high according to the Society for Assisted Reproductive Technology. Nevertheless, infertility affects nearly 7 million Americans, with only about 24% of treatment needs currently met due to financial barriers and inconsistent insurance mandates.

Key Facts

Data indicate substantial disparities in IVF affordability:

  • An IVF cycle in Greece generally costs between $3,000 and $4,000 for procedures using a patient’s own eggs, excluding medication.
  • The Solomons’ two trips to Greece included ovulation stimulation, egg retrieval, fertilization, embryo transfer, and storage for approximately $12,000 total.
  • U.S. IVF medication costs have surged by nearly 90% since 2014, partially offset by government discount programs like TrumpRx, which may save patients up to $2,200 per cycle.
  • CNY Fertility, a U.S.-based provider, offers cycles around $8,000 but still sees many patients traveling out of state seeking affordable care.
  • American patient visits to European fertility clinics increased by more than 37% in 2025, according to the European Fertility Society.
  • Legal differences in countries like Greece affect embryo storage duration, donor anonymity, and eligibility criteria for procedures such as surrogacy.
  • Nearly two to three IVF cycles are typically required for a successful live birth, compounding financial and emotional stresses.

What This Means

The steep and rising cost of IVF treatments in the U.S., compounded by inconsistent insurance coverage, is creating a significant access barrier for many hopeful parents. American patients are increasingly compelled to seek fertility care abroad, where procedures are more affordable and wait times shorter. This trend highlights systemic challenges in the U.S. healthcare system related to coverage of reproductive health services.

Traveling overseas for IVF introduces new complexities, including navigating foreign regulatory requirements, managing transportation of medications, and addressing continuity of care between countries. Patients may face difficulties in transferring medical records or understanding diagnoses obtained abroad. While international clinics provide cost relief, these hurdles necessitate cautious decision-making and often, considerable logistical effort.

Moreover, for some patients, fertility tourism can blend treatment with an emotionally supportive environment or vacation—potentially mitigating some psychological burdens associated with fertility procedures. However, economic disparities remain: traveling abroad is not a viable option for all, underscoring ongoing inequities in access to reproductive technologies.

Background

Infertility rates have been rising in the U.S., attributed to factors such as delayed childbearing and environmental influences like pollution. Despite this, insurance coverage for fertility treatments varies widely across states, with many plans excluding provisions for IVF or related reproductive services. This patchwork of policies contributes to the financial challenges faced by patients.

The current administration has proposed measures to improve employer-based fertility coverage, though these rules remain in development. Additionally, government initiatives have marginally lowered some medication costs, but these savings have not kept pace with the overall rise in IVF-related expenses.

Analysis

Experts such as Jakub Dejewski, chair of the European Fertility Society, note that American patients choose European clinics not only for affordability but also for quicker access and international patient support services these clinics provide. Penny Ampatzi, clinic director at Serum IVF in Athens, emphasizes that personalized care combined with reasonable costs attracts a growing number of foreign patients.

Within the U.S., William Kiltz of CNY Fertility describes the IVF market as emotionally charged, with prices often placing treatment out of reach for most except wealthier individuals. Providers aiming to reduce costs can sustain operations but often only at minimal profit margins, reflecting systemic inefficiencies.

Tarita Pakrashi, a reproductive specialist in Virginia, warns of the challenges patients face when pursuing overseas treatment—complex regulations, language barriers, and follow-up care issues can hinder successful outcomes and continuity.

What Comes Next

The U.S. government’s potential finalization of fertility coverage rules could improve financial accessibility for some patients, but no final regulatory changes have yet been enacted. Researchers and advocacy groups continue monitoring IVF costs and treatment accessibility, while clinics domestically and abroad adjust to shifting patient demands.

Sources

This article is based on reporting and publicly available information from the following sources:

Read more Health & Public Health stories on Goka World News.

Maya Tanaka
About the editor

Maya Tanaka

Maya Tanaka Role: Health Editor Maya Tanaka covers health policy, public health, medical research, and healthcare systems. Her reporting style emphasizes caution, verified medical sources, and clear explanations of what is confirmed, what remains uncertain, and why health-related news matters to the public.

View all posts by Maya Tanaka